Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin in Prosthetic Joint Infection
NCT05211011Phase 4Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fosfomycin in prosthetic joint infection (PJI), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
fosfomycin
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT05211011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05211011.